{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:27:51Z","timestamp":1785875271582,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea","award":["HI14C2202"],"award-info":[{"award-number":["HI14C2202"]}]},{"name":"Health & Welfare, Republic of Korea","award":["20-11-0-090-091-3000-3033-320"],"award-info":[{"award-number":["20-11-0-090-091-3000-3033-320"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.fct.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T22:00:50Z","timestamp":1492120850000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Anti-factor Xa activities of zingerone with anti-platelet aggregation activity"],"prefix":"10.1016","volume":"105","author":[{"given":"Wonhwa","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae-Kwang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sup","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2017.04.012_bib1","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.90.4.1624","article-title":"Hirudin in acute myocardial infarction. Safety report from the thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9A trial","volume":"90","author":"Antman","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.fct.2017.04.012_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.phymed.2013.10.007","article-title":"Zingerone regulates intestinal transit, attenuates behavioral and oxidative perturbations in irritable bowel disorder in rats","volume":"21","author":"Banji","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.fct.2017.04.012_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11239-006-5579-4","article-title":"New anticoagulants: anti IIa vs anti Xa\u2013is one better?","volume":"21","author":"Bauer","year":"2006","journal-title":"J.\u00a0Thromb. Thrombolysis"},{"key":"10.1016\/j.fct.2017.04.012_bib4","doi-asserted-by":"crossref","first-page":"10846","DOI":"10.1038\/srep10846","article-title":"A\u00a0novel direct factor Xa inhibitory peptide with anti-platelet aggregation activity from Agkistrodon acutus venom hydrolysates","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2017.04.012_bib5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)02225-X","article-title":"Blood coagulation","volume":"355","author":"Dahlback","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2017.04.012_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A\u00a0good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J.\u00a0Appl. Toxicol."},{"key":"10.1016\/j.fct.2017.04.012_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1042\/bj0550170","article-title":"The determination of enzyme inhibitor constants","volume":"55","author":"Dixon","year":"1953","journal-title":"Biochem. J."},{"key":"10.1016\/j.fct.2017.04.012_bib8","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.fct.2017.04.012_bib9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood.V95.3.894.003k15_894_902","article-title":"Platelet secretion induced by phorbol esters stimulation is mediated through phosphorylation of MARCKS: a MARCKS-derived peptide blocks MARCKS phosphorylation and serotonin release without affecting pleckstrin phosphorylation","volume":"95","author":"Elzagallaai","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.fct.2017.04.012_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/1947-2714.110430","article-title":"Winter cardiovascular diseases phenomenon","volume":"5","author":"Fares","year":"2013","journal-title":"N.\u00a0Am. J. Med. Sci."},{"key":"10.1016\/j.fct.2017.04.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0031-1272544","article-title":"Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations","volume":"20","author":"Ferraris","year":"2011","journal-title":"Int. J. Angiol."},{"key":"10.1016\/j.fct.2017.04.012_bib12","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI26987","article-title":"Thrombus formation in\u00a0vivo","volume":"115","author":"Furie","year":"2005","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.fct.2017.04.012_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1538-7836.2007.02308.x","article-title":"Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface","volume":"5","author":"Ghosh","year":"2007","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.fct.2017.04.012_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2004.02.059","article-title":"Ability of anti-glycoprotein IIb\/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions","volume":"44","author":"Goto","year":"2004","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.fct.2017.04.012_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jbt.21668","article-title":"Preventive effects of zingerone on altered lipid peroxides and nonenzymatic antioxidants in the circulation of isoproterenol-induced myocardial infarcted rats","volume":"29","author":"Hemalatha","year":"2015","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.fct.2017.04.012_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejphar.2016.08.023","article-title":"Anti-inflammatory and anti-thrombotic effects of zingerone in a rat model of myocardial infarction","volume":"791","author":"Hemalatha","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fct.2017.04.012_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0031-6997(25)06665-7","article-title":"Pharmacological receptors on blood platelets","volume":"43","author":"Hourani","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.fct.2017.04.012_bib18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/ATVBAHA.107.157479","article-title":"Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis","volume":"28","author":"Izuhara","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.fct.2017.04.012_bib19","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association\/American stroke association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.fct.2017.04.012_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.molbiopara.2011.01.008","article-title":"Ac-AP-12, a novel factor Xa anticoagulant peptide from the esophageal glands of adult Ancylostoma caninum","volume":"177","author":"Jiang","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.fct.2017.04.012_bib21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5483\/BMBRep.2016.49.4.220","article-title":"Anti-septic effects of dabrafenib on HMGB1-mediated inflammatory responses","volume":"49","author":"Jung","year":"2016","journal-title":"BMB Rep."},{"key":"10.1016\/j.fct.2017.04.012_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s12272-016-0743-7","article-title":"Suppressive effects of three diketopiperazines from marine-derived bacteria on TGFBIp-mediated septic responses in human endothelial cells and mice","volume":"39","author":"Jung","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.fct.2017.04.012_bib23","first-page":"1023","article-title":"Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome","volume":"56","author":"Katiyar","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.fct.2017.04.012_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.exger.2010.03.005","article-title":"Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway","volume":"45","author":"Kim","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.fct.2017.04.012_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5483\/BMBRep.2011.44.2.140","article-title":"PKC inhibitors RO 31-8220 and Go 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation","volume":"44","author":"Kim","year":"2011","journal-title":"BMB Rep."},{"key":"10.1016\/j.fct.2017.04.012_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5483\/BMBRep.2015.48.9.017","article-title":"Baicalin, baicalein and wogonin inhibits high glucose-induced vascular inflammation in\u00a0vitro and in\u00a0vivo","volume":"48","author":"Ku","year":"2015","journal-title":"BMB Rep."},{"key":"10.1016\/j.fct.2017.04.012_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5483\/BMBRep.2015.48.11.038","article-title":"Inhibitory effects of lysozyme on endothelial protein C receptor shedding in\u00a0vitro and in\u00a0vivo","volume":"48","author":"Ku","year":"2015","journal-title":"BMB Rep."},{"key":"10.1016\/j.fct.2017.04.012_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12272-016-0708-x","article-title":"Antithrombotic and antiplatelet activities of pelargonidin in\u00a0vivo and in\u00a0vitro","volume":"39","author":"Ku","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.fct.2017.04.012_bib29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12272-014-0410-9","article-title":"Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin","volume":"38","author":"Lee","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.fct.2017.04.012_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2014.10.124","article-title":"Myocardial infarction and atrial fibrillation: different impact of anti-IIa vs anti-Xa new oral anticoagulants: a meta-analysis of the interventional trials","volume":"178","author":"Loffredo","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.fct.2017.04.012_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(86)90073-2","article-title":"Prostaglandins, thromboxanes, and leukotrienes in inflammation","volume":"80","author":"Malmsten","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.fct.2017.04.012_bib32","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/01.CIR.102.16.1931","article-title":"P-selectin expression on platelets determines size and stability of platelet aggregates","volume":"102","author":"Merten","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.fct.2017.04.012_bib33","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/bi971147e","article-title":"Discovery of a novel, potent, and specific family of factor Xa inhibitors via combinatorial chemistry","volume":"37","author":"Ostrem","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.fct.2017.04.012_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3835(98)00081-0","article-title":"Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice","volume":"129","author":"Park","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.fct.2017.04.012_bib35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/1074248415578172","article-title":"Effects of rivaroxaban on platelet activation and platelet-coagulation pathway interaction: in\u00a0vitro and in\u00a0vivo studies","volume":"20","author":"Perzborn","year":"2015","journal-title":"J.\u00a0Cardiovasc Pharmacol. Ther."},{"key":"10.1016\/j.fct.2017.04.012_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/ATVBAHA.110.202978","article-title":"Rivaroxaban: a new oral factor Xa inhibitor","volume":"30","author":"Perzborn","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.fct.2017.04.012_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0973-7847.95849","article-title":"Historical review of medicinal plants' usage","volume":"6","author":"Petrovska","year":"2012","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.fct.2017.04.012_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00019501-199607000-00003","article-title":"Potential advantages of direct-acting thrombin inhibitors","volume":"7","author":"Philippides","year":"1996","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.fct.2017.04.012_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2011.02.002","article-title":"Protective effect of zingerone, a dietary compound against radiation induced genetic damage and apoptosis in human lymphocytes","volume":"657","author":"Rao","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fct.2017.04.012_bib40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.RES.0000261936.85776.5f","article-title":"In\u00a0vivo thrombus formation in murine models","volume":"100","author":"Sachs","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.fct.2017.04.012_bib41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1146\/annurev.bi.47.070178.005025","article-title":"Prostaglandins and thromboxanes","volume":"47","author":"Samuelsson","year":"1978","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.fct.2017.04.012_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02253465","article-title":"Thromboxanes: synthase and receptors","volume":"5","author":"Shen","year":"1998","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.fct.2017.04.012_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1054-3589(08)60986-2","article-title":"Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite","volume":"38","author":"Sies","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.fct.2017.04.012_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10739680590925682","article-title":"Interactions of platelets, blood-borne tissue factor, and fibrin during arteriolar thrombus formation in\u00a0vivo","volume":"12","author":"Sim","year":"2005","journal-title":"Microcirculation"},{"key":"10.1016\/j.fct.2017.04.012_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biochi.2014.07.006","article-title":"A\u00a0new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa","volume":"105","author":"Thakur","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.fct.2017.04.012_bib46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.2333510","article-title":"Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa","volume":"248","author":"Waxman","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.fct.2017.04.012_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2141.2009.07819.x","article-title":"New insights into the haemostatic function of platelets","volume":"147","author":"Wei","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.fct.2017.04.012_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.5483\/BMBRep.2015.48.10.044","article-title":"Anticoagulant and antiplatelet activities of scolymoside","volume":"48","author":"Yoon","year":"2015","journal-title":"BMB Rep."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691517301813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691517301813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:33:34Z","timestamp":1759527214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691517301813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":48,"alternative-id":["S0278691517301813"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2017.04.012","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-factor Xa activities of zingerone with anti-platelet aggregation activity","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}